NIVOLUMAB AND HYALURONIDASE-NVHY

136 reported adverse events

Drug classes: Endoglycosidase [EPC] Programmed Death Receptor-1 Blocking Antibody [EPC]

These side effects are most commonly reported by patients taking NIVOLUMAB AND HYALURONIDASE-NVHY:

# Side effect Count
0 OFF LABEL USE 35
1 FATIGUE 12
2 RASH 12
3 PRODUCT STORAGE ERROR 11
4 ARTHRALGIA 10
5 DEATH 8
6 DIARRHOEA 7
7 CONSTIPATION 6
8 DECREASED APPETITE 6
9 PRODUCT DOSE OMISSION ISSUE 6
See all common reactions for NIVOLUMAB AND HYALURONIDASE-NVHY

NIVOLUMAB AND HYALURONIDASE-NVHY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRANIAL NERVE PARALYSIS 1 0.0021
1 INGROWN HAIR 1 0.0014
2 CRANIAL NERVE DISORDER 1 0.0014
3 PRODUCT STORAGE ISSUE 5 0.0013
4 BENIGN NEOPLASM 1 0.0009
5 EYELID SKIN DRYNESS 1 0.0008
6 ADNEXA UTERI PAIN 1 0.0008
7 ABSCESS ORAL 1 0.0007
8 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
9 PRODUCT PREPARATION ISSUE 2 0.0003
See all enriched reactions for NIVOLUMAB AND HYALURONIDASE-NVHY